Presidents
Nicola Mozzillo
Honorary President
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Igor Puzanov
Director Early Phase Clinical Trials Program, Co-Leader Experimental Therapeutics Program, Chief Melanoma Section Department of Medicine Roswell Park Cancer Institute, Buffalo, NY
Ena Wang
Acting CRO
Research Chief, Translational Medicine Division, Research Branch, Sidra Medical and Research Center, Doha, Qatar
Scientific Board
Sanjiv Agarwala
Chief of Medical oncology and Hematology, St. Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon
Sandra Demaria
Weill Cornell medical College, New York, NY
Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland
Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon
Jerome Galon
INSERM (National Institute of Health and Medical Research), Paris, France
Claus Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany
Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Michael Postow
Memorial Sloan Kettering Cancer Center, New York
Igor Puzanov
Director Early Phase Clinical Trials Program, Co-Leader Experimental Therapeutics Program, Chief Melanoma Section Department of Medicine Roswell Park Cancer Institute, Buffalo, NY
Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland
Ena Wang
Acting CRO
Research Chief, Translational Medicine Division, Research Branch, Sidra Medical and Research Center, Doha, Qatar
For information please contact info@melanomabridge.org
